Lymphomatoid Papulosis
Showing 1 - 9 of 9
Mycosis Fungoides, Lymphomatoid Papulosis, Sezary Syndrome Trial in United States (brentuximab vedotin)
Recruiting
- Mycosis Fungoides
- +2 more
- brentuximab vedotin
-
Stanford, California
- +7 more
Nov 3, 2022
Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,
Not yet recruiting
- Mycosis Fungoides of Skin (Diagnosis)
- +5 more
- Med-Jet Injector
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023
Tissue Repository: CTCL Collection Protocol
Recruiting
- Lymphoma, T-Cell, Cutaneous
- +2 more
-
New York, New YorkColumbia University Medical Center
May 2, 2022
Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and
Recruiting
- Lymphomatoid Granulomatosis
- +3 more
- Interferon
- Rituxan and EPOCH
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Lymphoma, T-Cell, Cutaneous Trial in New York (AFM13)
Completed
- Lymphoma, T-Cell, Cutaneous
-
New York, New YorkCenter for Lymphoid Malignancies
Jul 14, 2020
Pityriasis Lichenoides : Anatomo-clinical Aspects and Follow-up
Unknown status
- Pityriasis Lichenoides
- (no location specified)
Apr 15, 2019
Lymphoma, Non-Hodgkin Trial (Tositumomab and Iodine I 131 Tositumomab)
Completed
- Lymphoma, Non-Hodgkin
- Tositumomab and Iodine I 131 Tositumomab
- (no location specified)
Nov 18, 2016
Multiple Sclerosis Trial in Worldwide (Fingolimod 0.5 mg, Fingolimod 1.25 mg)
Completed
- Multiple Sclerosis
- Fingolimod 0.5 mg
- Fingolimod 1.25 mg
-
Chatswood, Australia
- +104 more
Jun 9, 2012